SE8802066L - N-imidazolyl derivater av bicykliska foereningar anvaendbara inom medicin - Google Patents

N-imidazolyl derivater av bicykliska foereningar anvaendbara inom medicin

Info

Publication number
SE8802066L
SE8802066L SE8802066A SE8802066A SE8802066L SE 8802066 L SE8802066 L SE 8802066L SE 8802066 A SE8802066 A SE 8802066A SE 8802066 A SE8802066 A SE 8802066A SE 8802066 L SE8802066 L SE 8802066L
Authority
SE
Sweden
Prior art keywords
image
hydrogen
alkyl
societies
bicyclic
Prior art date
Application number
SE8802066A
Other languages
English (en)
Swedish (sv)
Other versions
SE8802066D0 (sv
Inventor
P Cozzi
C Ferti
P Salvati
G Carganico
A Pillan
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878712995A external-priority patent/GB8712995D0/en
Priority claimed from GB878712994A external-priority patent/GB8712994D0/en
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of SE8802066D0 publication Critical patent/SE8802066D0/xx
Publication of SE8802066L publication Critical patent/SE8802066L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8802066A 1987-06-03 1988-06-02 N-imidazolyl derivater av bicykliska foereningar anvaendbara inom medicin SE8802066L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878712995A GB8712995D0 (en) 1987-06-03 1987-06-03 N-imidazolyl derivatives
GB878712994A GB8712994D0 (en) 1987-06-03 1987-06-03 N-imidazolyl derivatives

Publications (2)

Publication Number Publication Date
SE8802066D0 SE8802066D0 (sv) 1988-06-02
SE8802066L true SE8802066L (sv) 1988-12-04

Family

ID=26292314

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8802066A SE8802066L (sv) 1987-06-03 1988-06-02 N-imidazolyl derivater av bicykliska foereningar anvaendbara inom medicin

Country Status (19)

Country Link
US (1) US4882347A (da)
JP (1) JPS63310825A (da)
KR (1) KR890000088A (da)
AU (1) AU608609B2 (da)
BE (1) BE1004551A3 (da)
CA (1) CA1310907C (da)
CH (1) CH675073A5 (da)
DE (1) DE3818741A1 (da)
DK (1) DK298088A (da)
FR (1) FR2616066B1 (da)
GB (1) GB2205240B (da)
HU (1) HU202105B (da)
IL (1) IL86552A (da)
IT (1) IT1217764B (da)
MY (1) MY103293A (da)
NL (1) NL8801422A (da)
PH (1) PH24144A (da)
PT (1) PT87634B (da)
SE (1) SE8802066L (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91542A0 (en) * 1988-10-06 1990-04-29 Erba Carlo Spa N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
US5368334A (en) * 1993-06-10 1994-11-29 Moore Business Forms, Inc. Variable data clear mark imaging
ATE252563T1 (de) * 1995-12-27 2003-11-15 Mitsubishi Pharma Corp Vorsorge-/heilmittel fur die komplikationen von diabetes
AU2381497A (en) * 1996-04-19 1997-11-12 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
US6043247A (en) * 1996-04-19 2000-03-28 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
JP2011517313A (ja) 2007-12-11 2011-06-02 ビアメト ファーマシューティカルズ，インク． 金属結合部分を標的化部分と組み合わせて使用する金属酵素阻害剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992403A (en) * 1975-05-30 1976-11-16 Schering Corporation 2-Imidazolines and their use as hypoglycemic agents
IL66242A0 (en) * 1981-07-23 1982-11-30 Erba Farmitalia N-imidazolyl derivatives of 1,2,3,4-tetrahydro-naphthalene,indan and 2-substituted-1-chroman,their preparation and pharmaceutical compositions containing them
ES523609A0 (es) * 1982-07-05 1985-03-01 Erba Farmitalia Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.
GB2141705B (en) * 1983-06-20 1986-09-24 Erba Farmitalia Imidazoles
US4634705A (en) * 1984-06-06 1987-01-06 Abbott Laboratories Adrenergic amidines

Also Published As

Publication number Publication date
FR2616066B1 (fr) 1992-05-07
IT1217764B (it) 1990-03-30
US4882347A (en) 1989-11-21
GB8812696D0 (en) 1988-06-29
SE8802066D0 (sv) 1988-06-02
HUT49484A (en) 1989-10-30
JPS63310825A (ja) 1988-12-19
CA1310907C (en) 1992-12-01
HU202105B (en) 1991-02-28
CH675073A5 (da) 1990-08-31
IT8820833A0 (it) 1988-06-02
PT87634B (pt) 1992-09-30
PH24144A (en) 1990-03-22
PT87634A (pt) 1988-07-01
IL86552A0 (en) 1988-11-15
BE1004551A3 (fr) 1992-12-15
AU1690588A (en) 1988-12-08
AU608609B2 (en) 1991-04-11
FR2616066A1 (fr) 1988-12-09
IL86552A (en) 1993-03-15
KR890000088A (ko) 1989-03-11
NL8801422A (nl) 1989-01-02
GB2205240B (en) 1991-01-09
DK298088D0 (da) 1988-06-01
MY103293A (en) 1993-05-29
GB2205240A (en) 1988-12-07
DE3818741A1 (de) 1988-12-22
DK298088A (da) 1988-12-04

Similar Documents

Publication Publication Date Title
DK164701C (da) Thiazolidinderivater, deres fremstilling og midler, som indeholder dem
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0585155T3 (da) Trifluormethylketon-peptidderivater med HLE-inhiberende aktivitet, deres fremstilling og farmaceutiske præparater
PA8451801A1 (es) Derivados de la 9-oxima eritromicina
NO921413D0 (no) Pyrazolopyridin-forbindelser og fremgangsmaate for fremstilling derav
MA22895A1 (fr) 7-(2-aminoethyl) benzothiazolones.
ES2118203T3 (es) Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
SE8802066L (sv) N-imidazolyl derivater av bicykliska foereningar anvaendbara inom medicin
DK0630252T3 (da) Farmaceutisk præparat på basis af rhamnolipid mod dermatologiske sygdomme
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
ES2014482B3 (es) Nuevas 2-tiazolil imidazo/1,2-a/pirimidinas y sus sales, su procedimiento de preparacion, su aplicacion a titulo de medicamentos y las composiciones que las encierran.
AR029001A1 (es) Derivados de bencil-3,4-metilendioxicinamico y el uso de los mismos para la manufactura de un medicamento
DE69217613D1 (de) Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DK148288D0 (da) N-phenethylaminoalkyl-benzamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende forbindelserne
FI913713A0 (fi) Nya bicykliska aminosubstituerade foereningar.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
EA200000374A2 (ru) Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции
KR930023338A (ko) 데포우 제제
TR200103473T2 (tr) Kristalli azabisiklo (2.2.2) oktan-3-amin sitratin polimorfları ve farmasötik kompozisyonları.
DK610586A (da) 5-aminoalkyl-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel
MX9302832A (es) Nuevo medicamento para el tratamiento de la arritmia.
MX9203068A (es) Compuestos activirales oralmente activos.
DK644487A (da) Farmaceutisk praeparat indeholdende en 2-oxo-imidazolidinforbindelse
ES2057542T3 (es) Agentes terapeuticos.
SE8303718L (sv) E-homo-enurnanderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa foreningar

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8802066-4

Effective date: 19940402

Format of ref document f/p: F